Joseph U. Igietseme - Infectious Diseases

Author Information

Joseph U. Igietseme is a leading researcher affiliated with the National Center for Emerging Zoonotic and Infectious Diseases at the Centers for Disease Control & Prevention in Atlanta, Georgia, USA. His work primarily focuses on infectious diseases, with a significant emphasis on understanding and combating pathogens such as Chlamydia and Plasmodium falciparum.

Research Contributions

Joseph U. Igietseme has made substantial contributions to the field of infectious diseases through his research on Chlamydia and malaria. His studies explore the cellular and molecular mechanisms underpinning Chlamydia pathogenesis and immune responses, aiming to improve vaccine efficacy and understand disease outcomes. Notably, his research has delved into the role of signaling pathways and the impact of external factors like shift work on Chlamydia infection outcomes. Additionally, his work on Plasmodium falciparum includes investigations into drug resistance and the physiological responses elicited by antimalarial treatments.

Aliases

Throughout his career, Joseph U. Igietseme has been referenced by various aliases including J U Igietseme, Joseph Igietseme, J. U. Igietseme, and J Igietseme. These variations are commonly found across different publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	125
Total Citations	3510
H-index	35

Publications:

MiR-378b Modulates Chlamydia-Induced Upper Genital Tract Pathology

DOI: 10.3390/pathogens10050566

Year: 2021

Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection

DOI: 10.3389/fimmu.2021.625318

Year: 2021

Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine

DOI: 10.3389/fimmu.2021.698737

Year: 2021

Author Correction: Shift work influences the outcomes of Chlamydia infection and pathogenesis

DOI: 10.1038/s41598-020-79099-z

Year: 2020

Epidermal Growth Factor Receptor and Transforming Growth Factor β Signaling Pathways Cooperate To Mediate Chlamydia Pathogenesis

DOI: 10.1128/IAI.00819-19

Year: 2020

EGFR and TGF-β Signaling Pathways Cooperate to Mediate Chlamydia Pathogenesis.

DOI: 10.1128/iai.00819-19

Year: 2020

Shift work influences the outcomes of Chlamydia infection and pathogenesis

DOI: 10.1038/s41598-020-72409-5

Year: 2020

Plasmodium falciparum treated with artemisinin-based combined therapy exhibits enhanced mutation, heightened cortisol and TNF induction

DOI: 10.21767/2472-1093-C1-002

Year: 2019

Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses

DOI: 10.3389/fimmu.2019.01577

Year: 2019

Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria

DOI: 10.1186/s12936-019-2947-z

Year: 2019

How Do They Monitor Disease Outbreaks?

How Does WHO Respond to Disease Outbreaks?

How Does Genomics Contribute to Vaccine Development?

What are the Symptoms of Dengue?

How Does a PCR Test Work?

What are the Clinical Implications of the Inflammatory Response?

What are Antimicrobial Therapies?

What is Fatigue?

How Are Infectious Diseases Transmitted?

How Do Polymerase Inhibitors Work?

Partnered Content Networks

Relevant Topics